Neurenati Therapeutics logo

Neurenati Therapeutics

Website

Team & Investors

Leadership, board of directors, and investment partners

Executives
0
Board Members
0
Investors
3
Total Funding
$4.3M
Investors
3 investors across all rounds
FR
Francois Ravenelle
GC
Genson Capital
IQ
Investissement Quebec
OTHER
Explore More Data
Detailed analysis for Neurenati Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

Neurenati Therapeutics Leadership & Investors

Neurenati Therapeutics is led by a team of experienced leaders. The company has attracted investment from 3 institutional and strategic investors.

Who Has Invested in Neurenati Therapeutics?

Neurenati Therapeutics has raised $4.3M from 3 investors including venture capital firms, private equity investors, and strategic partners.

Investment Opportunity

Accredited investors can access Neurenati Therapeutics shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.